Session Details

F122 Discoveries that Will Change Your Practice: Basic Science Updates for Dermatologists

Mon, Mar 11, 3:30 PM - 5:30 PM
Room 30B
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

The session will be focused on reviewing recent basic science discoveries within lupus, dermatomyositis, cutaneous T-Cell lymphoma, melanoma, the microbiome and neuropathic itch and their impact on the practice of dermatology. The session will be directed toward practicing dermatologists looking to stay up to date with scientific literature and dermatology residents looking for additional board preparation and practice preparation.

Scientific literature is expanding at a rate that makes reviewing all pertinent literature in one's field impossible. Practicing dermatologists often find it difficult to keep up with basic science advances, in favor of reading clinical journals. However, basic science advances inform therapeutic options, and prognostication of side effects, response to therapy and patient survival. Our goal is to translate recent scientific advances into actionable clinical practice updates.

LEARNING OBJECTIVES

1.

Summarize updates in microbiome research and the effects on the practice of dermatology

2.

Summarize updates in the pathogenesis of lupus, dermatomyositis, cutaneous T cell lymphoma, melanoma, and neuropathic itch and the effects on the practice of dermatology

SCHEDULE

10:30 PM

Advances in neuropathic itch

Jesse J Keller, MD, FAAD

10:50 PM

Microbiome in dermatology

Teri Seeberger Greiling, MD, PhD, FAAD

11:10 PM

Advances in Mucosal Dermatology

Erin Foster, MD, FAAD

11:30 PM

Molecular diagnosis/mutation analysis as prognostic factors in melanoma

Elizabeth Gates Berry, MD, FAAD

11:50 PM

Cutaneous T-cell lymphoma

Jina Chung, MD, FAAD

12:10 AM

Panel discussion/Q&A

SPEAKERS

Elizabeth Gates Berry, MD, FAAD

Elizabeth Gates Berry, MD, FAAD

Jina Chung, MD, FAAD

Jina Chung, MD, FAAD

Erin Foster, MD, FAAD

Erin Foster, MD, FAAD

Teri Seeberger Greiling, MD, PhD, FAAD

Teri Seeberger Greiling, MD, PhD, FAAD

Jesse J Keller, MD, FAAD

Jesse J Keller, MD, FAAD

SPEAKER DISCLOSURES

Elizabeth Gates Berry, MD, FAAD

Barco N.V. – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Fees); Orlucent – Investigator(Grants/Research Funding);

Jina Chung, MD, FAAD

No financial relationships exist with ineligible companies.

Erin Foster, MD, FAAD

Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); National Eczema Association – Consultant (1099 relationship)(No Compensation Received);

Teri Seeberger Greiling, MD, PhD, FAAD

Biogen – Independent Contractor(Salary); Concerto Biosciences – Consultant (1099 relationship)(Honoraria); Janssen Scientific Affairs, LLC – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria); Schro¨dinger, Inc – Consultant (1099 relationship)(Honoraria); UpToDate – Consultant(Honoraria); VisualDx – Consultant (1099 relationship)(Honoraria);

Jesse J Keller, MD, FAAD

No financial relationships exist with ineligible companies.